Welcome to our dedicated page for Crocs SEC filings (Ticker: CROX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Crocs, Inc. (Nasdaq: CROX) files reports and disclosures with the U.S. Securities and Exchange Commission that provide detailed information about its operations as a footwear manufacturing company. These SEC filings complement the company’s press releases by presenting formal financial statements, governance updates, and other material information.
Among the key documents available are current reports on Form 8-K, which Crocs, Inc. uses to announce significant events. For example, the company has filed 8-Ks to furnish quarterly earnings press releases under Item 2.02 (Results of Operations and Financial Condition) and to disclose executive appointments and resignations, along with related compensation terms, under Item 5.02 (Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).
Investors researching CROX can use the SEC filings page to locate quarterly and annual reports (Forms 10-Q and 10-K), which contain consolidated financial statements, segment information for the United States and other countries, and discussions of risk factors and business operations. These filings expand on the revenue, margin, cash flow, and balance sheet data summarized in press releases, and provide additional context on non-GAAP measures referenced by the company.
The filings page is also a resource for tracking executive compensation and governance arrangements, such as offer letters, separation agreements, and participation in incentive and change-in-control plans, which are often described or incorporated by reference in 8-K exhibits. In addition, investors can review disclosures related to cost savings initiatives, capital structure, and other matters that may be discussed in management’s commentary.
With real-time updates from EDGAR and AI-powered summaries, this page helps users quickly understand the substance of Crocs, Inc.’s SEC filings, from earnings-related 8-Ks to longer-form 10-K and 10-Q reports, without having to parse every technical detail manually.
Crocs, Inc. (CROX) reported an insider equity transfer and gift by a director and Chief Executive Officer. On 11/20/2025, the reporting person gifted 40,000 shares of Crocs common stock that were indirectly owned, at a stated price of $0, indicating a charitable or other non-sale transfer. After this transaction, the reporting person beneficially owns 775,981 shares indirectly and 341,265 shares directly.
The filing explains that 736,233 shares previously held directly by the reporting person were transferred to the REES FAMILY LIVING TRUST U/A DTD 03/22/2019. The reporting person serves as trustee of this trust and exercises voting and investment power over the shares it beneficially owns, so overall economic exposure is largely maintained but held in a different ownership structure.
Crocs, Inc. (CROX) disclosed an insider purchase on Form 4. A director bought 3,000 shares of common stock on 11/11/2025 at $74.50 per share (transaction code P). After the transaction, the director beneficially owns 18,417 shares, held directly.
Crocs, Inc. (CROX) reported that it issued a press release covering results for the three and nine months ended September 30, 2025. The company furnished this release as Exhibit 99.1 to its Form 8‑K.
The filing cites Item 2.02 (Results of Operations and Financial Condition) and notes that the press release is dated October 30, 2025. Crocs’ common stock trades on the Nasdaq Global Select Market under the symbol CROX.
Insider grant of restricted stock units to Crocs CFO. The filing shows that Reagan Patraic, EVP and Chief Financial Officer of Crocs, Inc. (CROX), was granted 45,372 restricted stock units under the companys 2020 Equity Incentive Plan on 09/22/2025. Each unit represents the right to one share of common stock and vests in five installments: 21.43% on 03/22/2026, 21.43% on 09/22/2026, 21.43% on 03/22/2027, 21.43% on 09/22/2027, and 14.28% on 09/22/2028, contingent on continued employment.
Reagan Patraic submitted an Initial Statement of Beneficial Ownership reporting her role as EVP, Chief Financial Officer of Crocs, Inc. (CROX). The filing states that no securities are beneficially owned by the reporting person at the time of this statement. The form identifies the reporting person's address and confirms this is an individual filing by one reporting person.
Crocs, Inc. reporting person Susan L. Healy, EVP and Chief Financial Officer, purchased 2,000 shares of Crocs common stock on 08/12/2025 at $76.56 per share. After the purchase she beneficially owns 50,078 shares. The Form 4 was signed by an attorney-in-fact on 08/14/2025. No derivative transactions or additional remarks are reported.
John B. Replogle, a director of Crocs, Inc. (CROX), reported purchases of company stock on 08/08/2025. He acquired 336 shares at a weighted-average price of $76.302 and 2,925 shares at a weighted-average price of $76.734, for a total of 3,261 shares added to his holdings. The filings show beneficial ownership of 12,492 shares after the first reported purchase and 15,417 shares following the second reported purchase.
The report discloses that the purchases were executed in multiple transactions with price ranges of $75.550 to $76.426 and $76.595 to $76.750 for the two groups of shares, respectively, and the filer's footnotes offer to provide a breakdown of shares purchased at each price upon request.
WIT Partners Advisory Pte. Ltd., a Singapore investment adviser, reports beneficial ownership of 2,852,280 shares of Crocs, Inc. common stock, representing 5.19% of the class. The filing states the reporting person has sole voting power and sole dispositive power over those shares and reports no shared voting or dispositive power.
The document is submitted as a Schedule 13G disclosure and includes certifications that the foreign regulatory scheme applicable to the reporting person is substantially comparable to the U.S. scheme and that the securities were not acquired to change or influence control of the issuer.
FAQ
What is the current stock price of Crocs (CROX)?
What is the market cap of Crocs (CROX)?
